Florida Senate - 2019 CS for SB 104 By the Committee on Health Policy; and Senator Book 588-02164-19 2019104c1 1 A bill to be entitled 2 An act relating to the Prescription Drug Donation 3 Repository Program; creating s. 465.1902, F.S.; 4 providing a short title; defining terms; creating the 5 Prescription Drug Donation Repository Program within 6 the Department of Health; specifying the purpose of 7 the program; authorizing the department to contract 8 with a third-party vendor to administer the program; 9 specifying entities that are eligible donors; 10 authorizing certain local repositories to accept a 11 donation from specified persons under certain 12 conditions; prohibiting a centralized repository or a 13 local repository from accepting donations from 14 unauthorized donors; providing criteria and procedures 15 for eligible donations; prohibiting donations to 16 specific patients; providing that certain prescription 17 drugs eligible for return to stock must be credited to 18 Medicaid and may not be donated under the program; 19 prohibiting the donation of certain drugs pursuant to 20 federal restrictions; clarifying that a repository is 21 not required to accept donations of prescription drugs 22 or supplies; providing inspection, inventory, and 23 storage requirements for centralized and local 24 repositories; requiring inspection of donated 25 prescription drugs and supplies by a licensed 26 pharmacist; requiring a local repository to notify the 27 centralized repository within a specified timeframe 28 after receiving a donation of prescription drugs or 29 supplies; authorizing the centralized repository to 30 redistribute prescription drugs or supplies; 31 authorizing a local repository to transfer 32 prescription drugs or supplies to another local 33 repository with authorization from the centralized 34 repository; requiring a local repository to notify the 35 department of its intent to participate in the 36 program; providing notification requirements; 37 providing a procedure for a local repository to 38 withdraw from participation in the program; requiring 39 the department to adopt rules regarding the 40 disposition of prescription drugs and supplies of a 41 withdrawing local repository; specifying conditions 42 for dispensing donated prescription drugs and supplies 43 to eligible patients; providing intake collection form 44 requirements; requiring a local repository to issue an 45 eligible patient who completes an intake collection 46 form a program identification card; prohibiting the 47 sale of donated prescription drugs and supplies under 48 the program; authorizing a repository to charge the 49 patient a nominal handling fee for the preparation and 50 dispensing of prescription drugs or supplies under the 51 program; requiring repositories to establish a 52 protocol for notifying recipients of a prescription 53 drug recall; providing for destruction of donated 54 prescription drugs under certain circumstances; 55 providing recordkeeping requirements; requiring the 56 centralized repository to submit an annual report to 57 the department; requiring the department or contractor 58 to establish, maintain, and publish a registry of 59 participating local repositories and available donated 60 prescription drugs and supplies; requiring the 61 department to publish certain information and forms on 62 its website; providing immunity from civil and 63 criminal liability and from professional disciplinary 64 action for participants under certain circumstances; 65 providing immunity to pharmaceutical manufacturers, 66 under certain circumstances, from any claim or injury 67 arising from the donation of any prescription drug or 68 supply under the program; requiring dispensers to 69 provide certain notice to patients; authorizing the 70 department to establish a direct-support organization 71 to provide assistance, funding, and promotional 72 support for program activities; providing 73 organizational requirements for a direct-support 74 organization; specifying direct-support organization 75 purposes and objectives; prohibiting the direct 76 support organization from lobbying; specifying that 77 the direct-support organization is not a lobbying 78 firm; prohibiting the direct-support organization from 79 possessing prescription drugs on behalf of the 80 program; providing limitations on expenditures of such 81 direct-support organizations; specifying that the 82 direct-support organization must operate under 83 contract with the department; specifying required 84 contract terms; providing for the direct-support 85 organization board of directors; specifying the 86 board’s membership requirements; specifying 87 requirements and requiring the department to adopt 88 rules relating to a direct-support organization’s use 89 of department property; specifying requirements for 90 the deposit and use of funds by the direct-support 91 organization; providing for annual audits of a direct 92 support organization; providing for future legislative 93 review and repeal of provisions relating to the 94 direct-support organization; requiring the department 95 to adopt rules; amending s. 252.36, F.S.; authorizing 96 the Governor to waive program patient eligibility 97 requirements during a declared state of emergency; 98 providing an effective date. 99 100 Be It Enacted by the Legislature of the State of Florida: 101 102 Section 1. Section 465.1902, Florida Statutes, is created 103 to read: 104 465.1902 Prescription Drug Donation Repository Program.— 105 (1) SHORT TITLE.—This section may be cited as the 106 “Prescription Drug Donation Repository Program Act.” 107 (2) DEFINITIONS.—As used in this section, the term: 108 (a) “Centralized repository” means a distributor permitted 109 under chapter 499 who is approved by the department or the 110 contractor to accept, inspect, inventory, and distribute donated 111 drugs and supplies under this section. 112 (b) “Closed drug delivery system” means a system in which 113 the actual control of the unit-dose medication package is 114 maintained by the facility, rather than by the individual 115 patient. 116 (c) “Contractor” means the third-party vendor approved by 117 the department to implement and administer the program as 118 authorized in subsection (4). 119 (d) “Controlled substance” means any substance listed under 120 Schedule II, Schedule III, Schedule IV, or Schedule V of s. 121 893.03. 122 (e) “Direct-support organization” means the entity created 123 under subsection (15). 124 (f) “Dispenser” means a health care practitioner who, 125 within the scope of his or her practice act, is authorized to 126 dispense medicinal drugs and who does so under this act. 127 (g) “Donor” means an entity specified in subsection (5). 128 (h) “Eligible patient” means a Florida resident who is 129 indigent, uninsured, or underinsured and who has a valid 130 prescription for a prescription drug or supply that may be 131 dispensed under the program. 132 (i) “Free clinic” means a clinic that delivers only medical 133 diagnostic services or nonsurgical medical treatment free of 134 charge to low-income recipients. 135 (j) “Health care practitioner” or “practitioner” means a 136 practitioner licensed under this chapter, chapter 458, chapter 137 459, chapter 461, chapter 463, chapter 464, or chapter 466. 138 (k) “Indigent” means an individual whose family income for 139 the 12 months preceding the determination of income is below 200 140 percent of the federal poverty level as defined by the most 141 recently revised poverty income guidelines published by the 142 United States Department of Health and Human Services. 143 (l) “Local repository” means a health care practitioner’s 144 office, a pharmacy, a hospital with a closed drug delivery 145 system, a nursing home facility with a closed drug delivery 146 system, or a free clinic or nonprofit health clinic that is 147 licensed or permitted to dispense medicinal drugs in the state. 148 (m) “Nonprofit health clinic” means a nonprofit legal 149 entity that provides medical care to patients who are indigent, 150 uninsured, or underinsured. The term includes, but is not 151 limited to, a federally qualified health center as defined in 42 152 U.S.C. s. 1396d(l)(2)(B) and a rural health clinic as defined in 153 42 U.S.C. s. 1396d(l)(1). 154 (n) “Nursing home facility” has the same meaning as in s. 155 400.021. 156 (o) “Prescriber” means a health care practitioner who, 157 within the scope of his or her practice act, is authorized to 158 prescribe medicinal drugs. 159 (p) “Prescription drug” has the same meaning as the term 160 “medicinal drugs” or “drugs,” as those terms are defined in s. 161 465.003(8), but does not include controlled substances or cancer 162 drugs donated under s. 499.029. 163 (q) “Program” means the Prescription Drug Donation 164 Repository Program created by this section. 165 (r) “Supplies” means any supply used in the administration 166 of a prescription drug. 167 (s) “Tamper-evident packaging” means a package that has one 168 or more indicators or barriers to entry which, if breached or 169 missing, can reasonably be expected to provide visible evidence 170 to consumers that tampering has occurred. 171 (t) “Underinsured” means a person who has third-party 172 insurance or is eligible to receive prescription drugs or 173 supplies through the Medicaid program or any other prescription 174 drug program funded in whole or in part by the Federal 175 Government, but who has exhausted these benefits or does not 176 have prescription drug coverage for the drug prescribed. 177 (u) “Uninsured” means a person who has no third-party 178 insurance and is not eligible to receive prescription drugs or 179 supplies through the Medicaid program or any other prescription 180 drug program funded in whole or in part by the Federal 181 Government. 182 (3) PRESCRIPTION DRUG DONATION REPOSITORY PROGRAM; 183 CREATION; PURPOSE.—The Prescription Drug Donation Repository 184 Program is created within the department for the purpose of 185 authorizing and facilitating the donation of prescription drugs 186 and supplies to eligible patients. 187 (4) PROGRAM IMPLEMENTATION; ADMINISTRATION.—The department 188 may contract with a third-party vendor to administer the 189 program. 190 (5) DONOR ELIGIBILITY.— 191 (a) The centralized repository or a local repository may 192 accept a donation of a prescription drug or supply from: 193 1. Nursing home facilities with closed drug delivery 194 systems. 195 2. Hospices that have maintained control of a patient’s 196 prescription drugs. 197 3. Hospitals with closed drug delivery systems. 198 4. Pharmacies. 199 5. Drug manufacturers or wholesale distributors. 200 6. Medical device manufacturers or suppliers. 201 7. Prescribers who receive prescription drugs or supplies 202 directly from a drug manufacturer, wholesale distributor, or 203 pharmacy. 204 (b) In addition to the donors specified in paragraph (a), a 205 local repository that qualifies as a free clinic or nonprofit 206 health clinic may accept a donation from a patient or a 207 patient’s legal representative or next of kin if the following 208 requirements are met: 209 1. An affidavit, in a format approved by the department, 210 signed by the donor must accompany the donation, identify the 211 prescribing health care practitioner, and attest to the 212 authenticity of the prescription drug or medical supply being 213 donated; 214 2. The prescription drug or medical supply being donated is 215 in its original tamper-evident packaging, in accordance with 216 subparagraph (6)(b)1., and does not have any physical signs of 217 tampering, misbranding, deterioration, compromised integrity, or 218 adulteration; 219 3. Any drug being donated has an expiration date that is 220 more than 3 months after the date of the donation; and 221 4. A licensed pharmacist inspects the prescription drug or 222 medical supply and can attest to the authenticity of the donated 223 prescription drug or medical supply and that it meets the 224 requirements of this paragraph. 225 226 Prescription drugs and supplies accepted under this paragraph 227 are exempt from subparagraph (6)(b)3. but are subject to all 228 other applicable requirements of subsections (6) and (7). 229 (c) Donations of prescription drugs or supplies may not be 230 accepted by the centralized repository or a local repository 231 from any donor not authorized under this subsection. 232 (6) PRESCRIPTION DRUGS AND SUPPLIES ELIGIBLE FOR DONATION; 233 DONATION REQUIREMENTS; PROHIBITED DONATIONS.— 234 (a) Only prescription drugs and supplies that have been 235 approved for medical use in the United States and that meet the 236 criteria for donation established by this section may be 237 accepted for donation under the program. Donations must be made 238 on the premises of the centralized repository or a local 239 repository to a person designated by the repository. A drop box 240 may not be used to accept donations. 241 (b) The centralized repository or a local repository may 242 accept a prescription drug only if: 243 1. The drug is in its original sealed and tamper-evident 244 packaging. Single-unit-dose drugs may be accepted if the single 245 unit-dose packaging is unopened. 246 2. The drug requires storage at normal room temperature per 247 the manufacturer or the United States Pharmacopeia. 248 3. The drug has been stored according to manufacturer or 249 United States Pharmacopeia storage requirements. 250 4. The drug does not have any physical signs of tampering 251 or adulteration and there is no reason to believe that the drug 252 is adulterated. 253 5. The packaging does not have any physical signs of 254 tampering, misbranding, deterioration, compromised integrity, or 255 adulteration. 256 6. The packaging indicates the lot number and expiration 257 date of the drug. If the lot number is not retrievable, all 258 specified medications must be destroyed in the event of a 259 recall. 260 7. The drug has an expiration date that is more than 3 261 months after the date that the drug was donated. 262 (c) The centralized repository or a local repository may 263 accept supplies only if they are in their original, unopened, 264 sealed packaging and have not been tampered with or misbranded. 265 (d) Prescription drugs or supplies may not be donated to a 266 specific patient. 267 (e) Prescription drugs billed to and paid for by Medicaid 268 in long-term care facilities which are eligible for return to 269 stock under federal Medicaid regulations must be credited to 270 Medicaid and may not be donated under the program. 271 (f) Prescription drugs with an approved Federal Food and 272 Drug Administration Risk Evaluation and Mitigation Strategy that 273 includes Elements to Assure Safe Use are not eligible for 274 donation under the program. 275 (g) This section does not require the centralized 276 repository or a local repository to accept a donation of 277 prescription drugs or supplies. 278 (7) INSPECTION AND STORAGE.— 279 (a) A licensed pharmacist employed by or under contract 280 with the centralized repository or a local repository shall 281 inspect donated prescription drugs and supplies to determine 282 whether they meet the requirements of subsections (5) and (6). 283 (b) The inspecting pharmacist must sign an inspection 284 record on a form prescribed by the department by rule which 285 verifies that the prescription drugs and supplies meet the 286 criteria of subsections (5) and (6) and must attach the record 287 to the inventory required by paragraph (d). A local repository 288 that receives drugs and supplies from the centralized repository 289 is not required to reinspect them. 290 (c) The centralized repository and local repositories shall 291 store donated prescription drugs and supplies in a secure 292 storage area under the environmental conditions specified by the 293 manufacturer or the United States Pharmacopeia for the 294 respective prescription drugs or supplies. Donated prescription 295 drugs and supplies may not be stored with other inventory. A 296 local repository shall quarantine donated prescription drugs or 297 supplies until they are inspected and approved for dispensing 298 under this section. 299 (d) The centralized repository and local repositories shall 300 maintain an inventory of all donated prescription drugs or 301 supplies. Such inventory at local repositories shall be recorded 302 on a form prescribed by the department by rule. 303 (e) A local repository shall notify the centralized 304 repository within 5 days after receipt of any donation of 305 prescription drugs or supplies to the program. The notification 306 must be on a form prescribed by the department by rule. 307 (f) The centralized repository may redistribute 308 prescription drugs and supplies by transferring them to or from 309 the centralized repository and a local repository, as needed. A 310 local repository that receives donated prescription drugs or 311 supplies may, with authorization from the centralized 312 repository, distribute the prescription drugs or supplies to 313 another local repository. 314 (8) PROGRAM PARTICIPATION.— 315 (a) A practitioner, pharmacy, facility, or clinic must 316 notify the department of its intent to participate in the 317 program as a local repository before accepting or dispensing any 318 prescription drugs or supplies pursuant to this section. The 319 notification must be made on a form prescribed by the department 320 by rule and must, at a minimum, include: 321 1. The name, street address, website, and telephone number 322 of the intended local repository and any license or registration 323 number issued by the state to the intended local repository, 324 including the name of the issuing agency. 325 2. The name and telephone number of the pharmacist employed 326 by or under contract with the intended local repository who is 327 responsible for the inspection of donated prescription drugs and 328 supplies. 329 3. A signed and dated statement by the responsible 330 pharmacist affirming that the intended local repository meets 331 the eligibility requirements of this section. 332 (b) A local repository may withdraw from participation in 333 the program at any time by providing written notice to the 334 department or contractor, as appropriate, on a form prescribed 335 by the department by rule. The department shall adopt rules 336 addressing the disposition of prescription drugs and supplies in 337 the possession of the withdrawing local repository. 338 (9) DISPENSING REQUIREMENTS; PROHIBITIONS.— 339 (a) Each eligible patient without a program identification 340 card must submit an intake collection form to a local repository 341 before receiving prescription drugs or supplies under the 342 program. The department shall prescribe a form by rule, which 343 must include at least all of the following: 344 1. The name, street address, and telephone number of the 345 eligible patient. 346 2. The basis for eligibility, which must specify that the 347 patient is indigent, uninsured, or underinsured. 348 3. A statement signed and dated by the eligible patient 349 affirming that he or she meets the eligibility requirements of 350 this section. 351 (b) Upon receipt of a completed and signed intake 352 collection form, the local repository shall issue him or her a 353 program identification card, which is valid for 1 year after its 354 date of issuance. The card must be in a form prescribed by the 355 department by rule. 356 (c) The local repository shall send a summary of each 357 intake collection form to the centralized pharmacy within 5 days 358 after receiving it. 359 (d) A dispenser may dispense donated prescription drugs or 360 supplies only to an eligible patient who has a program 361 identification card or who has submitted a completed intake 362 collection form. 363 (e) A dispenser shall inspect the donated prescription 364 drugs or supplies before dispensing them. 365 (f) A dispenser may provide dispensing and consulting 366 services to an eligible patient. 367 (g) Donated prescription drugs and supplies may not be sold 368 or resold under the program. 369 (h) A dispenser of donated prescription drugs or supplies 370 may not submit a claim or otherwise seek reimbursement from any 371 public or private third-party payor for donated prescription 372 drugs or supplies dispensed under this program. However, a 373 repository may charge the patient a nominal handling fee, 374 established by department rule, for the preparation and 375 dispensing of prescription drugs or supplies under the program. 376 (10) RECALLED PRESCRIPTION DRUGS AND SUPPLIES.— 377 (a) The centralized repository and each local repository 378 shall establish and follow a protocol for notifying recipients 379 in the event of a prescription drug recall. 380 (b) Local repositories shall destroy all recalled or 381 expired prescription drugs and all prescription drugs that are 382 not suitable for dispensing in the repository. Local 383 repositories must complete a destruction information form for 384 all such drugs, in accordance with department rule. 385 (11) RECORDKEEPING.— 386 (a) Local repositories shall maintain records of 387 prescription drugs and supplies that are accepted, donated, 388 dispensed, distributed, or destroyed under the program. 389 (b) All required records must be maintained in accordance 390 with any applicable practice act. Local repositories shall 391 submit these records quarterly to the centralized repository for 392 data collection, and the centralized repository shall submit 393 these records and the collected data in annual reports to the 394 department. 395 (12) REGISTRIES; PUBLICATION OF FORMS.— 396 (a) The department or contractor shall establish and 397 maintain registries of all local repositories and of 398 prescription drugs and supplies available under the program. The 399 registry of local repositories must include each repository’s 400 name, address, website, and telephone number. The registry of 401 available prescription drugs and supplies must include the name, 402 strength, available quantity, and expiration date of the 403 prescription drug or supplies and the name and contact 404 information of each repository where such drug or supplies are 405 available. The department shall publish the registries on its 406 website. 407 (b) The department shall publish all forms required by this 408 section on its website. 409 (13) IMMUNITY FROM LIABILITY, DISCIPLINARY ACTION.— 410 (a) Any donor of prescription drugs or supplies and any 411 participant in the program who exercises reasonable care in 412 donating, accepting, distributing, or dispensing prescription 413 drugs or supplies under the program is immune from civil or 414 criminal liability and from professional disciplinary action by 415 the state for any injury, death, or loss to person or property 416 relating to such activities. 417 (b) A pharmaceutical manufacturer who exercises reasonable 418 care is not liable for any claim or injury arising from the 419 donation of any prescription drug or supply under this section, 420 including, but not limited to, liability for failure to transfer 421 or communicate product or consumer information regarding the 422 donated prescription drug, including its expiration date. 423 (14) NOTICE TO PATIENTS.—Before dispensing a donated 424 prescription drug under the program, the dispenser must provide 425 written notification to the eligible patient or his or her legal 426 representative, receipt of which must be acknowledged in 427 writing, of all of the following information: 428 (a) The prescription drug was donated to the program. 429 (b) The donors and participants in the program are immune 430 from civil or criminal liability or disciplinary action. 431 (c) The eligible patient is not required to pay for the 432 prescription drug, but may be required to pay a nominal handling 433 fee, which may not exceed the amount established by department 434 rule. 435 (15) DIRECT-SUPPORT ORGANIZATION.—The department may 436 establish a direct-support organization to provide assistance, 437 funding, and promotional support for the activities authorized 438 under the act. 439 (a) Entity organization.—The direct-support organization 440 must operate in accordance with s. 20.058 and is: 441 1. A Florida corporation not for profit incorporated under 442 chapter 617, exempted from filing fees, and approved by the 443 Department of State. 444 2. Organized and operated to conduct programs and 445 activities; raise funds and request and receive grants, gifts, 446 and bequests of moneys; acquire, receive, hold, and invest, in 447 its own name, securities, funds, objects of value, or other 448 property, either real or personal; and make expenditures or 449 provide funding to or for the direct or indirect benefit of the 450 program. 451 (b) Purposes and objectives.—The purposes and objectives of 452 the direct-support organization must be consistent with the 453 goals of the department, in the best interest of the state, and 454 in accordance with the adopted goals and the mission of the 455 department. 456 (c) Prohibition against lobbying.—The direct-support 457 organization is not considered a lobbying firm, as that term is 458 defined in s. 11.045(1). All expenditures of the direct-support 459 organization must be directly related to program administration 460 within the requirements of this section. Funds of the direct 461 support organization may not be used for the purpose of 462 lobbying, as that term is defined in s. 11.045(1). 463 (d) Possession of prescription drugs.—The direct-support 464 organization may not possess any prescription drugs on behalf of 465 the program. 466 (e) Contract.—The direct-support organization shall operate 467 under a written contract with the department. 468 1. The contract must require the direct-support 469 organization to submit to the department, annually by August 1, 470 the following information, which must be posted on the websites 471 of the direct-support organization and the department: 472 a. The articles of incorporation and bylaws of the direct 473 support organization, as approved by the department. 474 b. A proposed annual budget for the approval of the 475 department. 476 c. The code of ethics of the direct-support organization. 477 d. The statutory authority or executive order that created 478 the direct-support organization. 479 e. A brief description of the direct-support organization’s 480 mission and any results obtained by the direct-support 481 organization. 482 f. A brief description of the direct-support organization’s 483 annual plan for each of the next 3 fiscal years. 484 g. A copy of the direct-support organization’s most recent 485 federal Internal Revenue Service Return Organization Exempt from 486 Income Tax form (Form 990). 487 h. Certification by the department that the direct-support 488 organization is complying with the terms of the contract and 489 operating in a manner consistent with the goals and purposes of 490 the department and the best interest of the program and the 491 state. Such certification must be made annually and reported in 492 the official minutes of a meeting of the board of directors of 493 the direct-support organization. 494 2. The contract must, at a minimum, provide for: 495 a. The reversion without penalty to the department, or to 496 the state if the department ceases to exist, of all moneys and 497 property held in trust by the direct-support organization for 498 the benefit of the program if the direct-support organization 499 ceases to exist or if the contract is terminated. 500 b. A disclosure of material provisions of the contract and 501 the distinction between the department and the direct-support 502 organization to appear on all promotional and fundraising 503 publications. 504 c. A list of prescription drugs solicited by the direct 505 support organization for distribution to the centralized 506 repository or a local repository. 507 (f) Board of directors.—The State Surgeon General shall 508 appoint the board of directors, which must consist of at least 5 509 members, but not more than 15 members, who serve at his or her 510 pleasure. The board must elect a chair from among its members. 511 Board members must serve without compensation but may be 512 entitled to reimbursement of travel and per diem expenses in 513 accordance with s. 112.061, if funds are available for this 514 purpose. 515 (g) Use of property.—The department may allow, without 516 charge, appropriate use of fixed property, facilities, and 517 personnel services of the department by the direct-support 518 organization for purposes related to the program. For purposes 519 of this paragraph, the term “personnel services” includes full 520 time or part-time personnel, as well as payroll processing 521 services. 522 1. The department may prescribe any condition with which 523 the direct-support organization must comply in order to use 524 fixed property or facilities of the department. 525 2. The department may not allow the use of any fixed 526 property or facilities of the department by the direct-support 527 organization if the organization does not provide equal 528 membership and employment opportunities to all persons 529 regardless of race, color, religion, sex, age, or national 530 origin. 531 3. The department shall adopt rules prescribing the 532 procedures by which the direct-support organization is governed 533 and any conditions with which a direct-support organization must 534 comply to use property or facilities of the department. 535 (h) Deposit of funds.—Any moneys of the direct-support 536 organization may be held in a separate depository account in the 537 name of the organization and subject to the provisions of the 538 organization’s contract with the department. 539 (i) Use of funds.—Funds designated for the direct-support 540 organization must be used for the enhancement of program 541 projects and in a manner consistent with that purpose. Any 542 administrative costs of running and promoting the purposes of 543 the organization or program must be paid by private funds. 544 (j) Audit.—The direct-support organization shall provide 545 for an annual financial audit in accordance with s. 215.981. 546 (k) Repeal.—This subsection is repealed on October 1, 2024, 547 unless reviewed and saved from repeal by the Legislature. 548 (16) RULEMAKING.—The department shall adopt rules necessary 549 to administer this section. When applicable, the rules may 550 provide for the use of electronic forms, recordkeeping, and 551 meeting by teleconference. 552 Section 2. Paragraph (o) is added to subsection (5) of 553 section 252.36, Florida Statutes, to read: 554 252.36 Emergency management powers of the Governor.— 555 (5) In addition to any other powers conferred upon the 556 Governor by law, she or he may: 557 (o) Waive the patient eligibility requirements of s. 558 465.1902. 559 Section 3. This act shall take effect July 1, 2019.